Page last updated: 2024-08-25

bendamustine hydrochloride and Brain Neoplasms

bendamustine hydrochloride has been researched along with Brain Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's5 (83.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y; Colapietro, A; Cristiano, L; Delle Monache, S; Festuccia, C; Gravina, GL; Mancini, A; Marampon, F; Mehrling, T; Pompili, S; Tombolini, V; Vetuschi, A; Vitale, F1
Hong, SH; Kang, JH; Kim, YS; Kwak, YK; Lee, SW; Sung, S1
Chinnaiyan, P; Neuger, A; Pan, E; Smith, P; Yu, D; Yu, HH; Zhao, X1
Chamberlain, MC; Colman, H; Kim, BT; Raizer, J1
Chamberlain, MC; Johnston, SK1
Höffken, K; Kath, R; Merkle, K; Semrau, R; Zulkowski, K1

Trials

3 trial(s) available for bendamustine hydrochloride and Brain Neoplasms

ArticleYear
Phase I study of bendamustine with concurrent whole brain radiation therapy in patients with brain metastases from solid tumors.
    Journal of neuro-oncology, 2014, Volume: 119, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Brain Neoplasms; Breast Neoplasms; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Combined Modality Therapy; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Maximum Tolerated Dose; Melanoma; Middle Aged; Nitrogen Mustard Compounds; Survival Analysis; Treatment Outcome

2014
Salvage therapy with bendamustine for temozolomide refractory recurrent anaplastic gliomas: a prospective phase II trial.
    Journal of neuro-oncology, 2017, Volume: 131, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Brain Neoplasms; Dacarbazine; Drug Resistance, Neoplasm; Female; Glioma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Prospective Studies; Salvage Therapy; Temozolomide; Treatment Outcome

2017
Salvage therapy with single agent bendamustine for recurrent glioblastoma.
    Journal of neuro-oncology, 2011, Volume: 105, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Brain Neoplasms; Disease-Free Survival; Female; Glioblastoma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Nitrogen Mustard Compounds; Salvage Therapy

2011

Other Studies

3 other study(ies) available for bendamustine hydrochloride and Brain Neoplasms

ArticleYear
The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma.
    Journal of hematology & oncology, 2018, 02-27, Volume: 11, Issue:1

    Topics: Animals; Antineoplastic Agents, Alkylating; Bendamustine Hydrochloride; Benzimidazoles; Brain Neoplasms; Cell Line, Tumor; Female; Glioblastoma; Histone Deacetylase Inhibitors; Humans; Mice; Vorinostat

2018
Intracranial control and survival outcome of tyrosine kinase inhibitor (TKI) alone versus TKI plus radiotherapy for brain metastasis of epidermal growth factor receptor-mutant non-small cell lung cancer.
    Journal of neuro-oncology, 2018, Volume: 139, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bendamustine Hydrochloride; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Chemoradiotherapy; Disease Progression; ErbB Receptors; Female; Humans; Incidence; Male; Middle Aged; Mutation; Protein Kinase Inhibitors; Protein-Tyrosine Kinases

2018
Regression of brain metastases from breast carcinoma after chemotherapy with bendamustine.
    Journal of cancer research and clinical oncology, 2002, Volume: 128, Issue:2

    Topics: Adult; Antineoplastic Agents; Bendamustine Hydrochloride; Brain Neoplasms; Breast Neoplasms; Female; Humans; Liver Neoplasms; Nitrogen Mustard Compounds; Treatment Outcome

2002